Industry Partners
We are grateful for the generous support from our industry partners.
The list of sponsors is in alphabetical order within the sponsorship level.
Please click on the company logo to find more information about our industry partners.
The list of exhibitors is in alphabetical order.
Please click on the company name to find more information about our industry partners.
Booth: B08
Accelera is a leading Contract Research Organization (CRO) specialized in preclinical toxicology studies for pharmaceutical and biotechnology companies, academic institutions, and healthcare organizations. Accelera delivers complete In-vivo services, from start to finish, across both rodent and non-rodent models, addressing the needs of various emerging modalities.
Booth: A30
At Alithea Genomics, we are excited to present our cutting-edge solutions for high-throughput sample multiplexing tailored to drug screening and biomarker discovery. Our innovative technologies streamline the sequencing workflow by enabling the simultaneous preparation of thousands of samples. This drastically reduces time, cost, and labor, allowing researchers to focus on data analysis and discovery. Join us as we delve into how our scalable solutions transform the transcriptomics field, offering unprecedented throughput and accuracy. We will showcase case studies demonstrating the impact of our technology on large-scale research projects and discuss how our innovations can empower the field of toxicology.
Booth: A14
AlveoliX is a Swiss biotech company dedicated to improving your laboratory experiments by offering top-notch equipment and consumables for organ-on-chip studies. We also offer specialized services for comprehensive drug safety and efficacy testing using our technology.
Our advanced in-vitro systems enables the modelling of all tissue barriers, including the associated mechanical forces. It is suitable for a wide range of applications including drug safety and efficacy testing, inhalation toxicology assessment and answering fundamental research questions.
Contact us to learn more about how our transformative approach can support your research.
Booth: A46
Aragen is a trusted R&D and manufacturing partner that transforms your ideas into solutions, keeping you ahead in the race for better health.
Booth: A66
Axion BioSystems is a leading life sciences tools company focused on innovative live-cell assays platforms to study the in-vitro function of cells for drug discovery, disease modelling, cancer immunotherapy, safety/toxicity, and more. Axion’s award-winning products are designed to accelerate scientific breakthroughs and transform therapeutic development from discovery to manufacturing.
The Maestro platform is a microelectrode array (MEA) and impedance system, allowing for non-invasive evaluation of your cells in an easy-to-use assay. Axion’s Omni platform combines imaging hardware with powerful image analysis algorithms to generate high-quality and robust data.
Booth: A62
At BASF, our Experimental Toxicology & Ecology team develops and applies innovative testing strategies to assess the toxicity and ecological impact of substances and products. As a GLP-certified laboratory with over 40 years of experience, we conduct hundreds of studies annually. Our commitment to animal welfare is demonstrated by our AAALAC accreditation, and we actively work on the development and validation of new approach methodologies (NAMs), being the first laboratory certified under GIVIMP. By collaborating with us, you can leverage our expertise in experimental (eco)toxicology to enhance product safety and ecological assessments. For more information, contact us at tox-contract-in@basf.com .
Booth: A18
BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, we specialize in control and disease state samples including human and animal tissues or preparations, cell and gene therapy products, blood, and other biofluids, as well as ADME contract research services from standalone bioanalytical support through tiered in vitro studies with submission-ready reports to customized consulting.
By combining our technical expertise, exceptional customer service, and unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
Booth: A03
Strategic Collaboration : Your one-stop access to all CRO and CDMO services in China, partnering with top-tier CDMOs, pharmacology CROs, and GLP-CROs.
Comprehensive Expertise: Full spectrum support in drug production, pharmacological testing, and preclinical studies.
Tailored Global Services: Our solutions are custom-designed for diverse markets across Asia-Pacific, North America, and Europe.
Cutting-Edge Research: State-of-the-art, genetically engineeredanimal modelsto drive global advancements in research and drugdevelopment.
Booth: A44
BiomimX, a spinoff of Politecnico di Milano, pioneers Organs on Chip (OoC) technology, creating cutting-edge in vitro models for drug discovery and testing. Our proprietary platform, uBeat®, integrates microfluidics, 3D cell culture, live human cells, and mechanical stimuli to produce “Beating OoCs.” These models replicate human physiology and pathology with remarkable precision, providing clinically relevant systems for drug safety and efficacy testing. BiomimX collaborates with regulatory bodies to advance OoC adoption in drug development, and data generated using our models have already supported IND applications, accelerating innovation and reliability in pharmaceutical research and development.
Booth: A37
BioSpyder Technologies Inc. has developed a novel product for targeted sequencing called TempO-Seq™, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, together with sequencing short fragments of each gene, enables pooling up to 6,144 samples in one sequencing run. Assay content is flexible and customizable delivering unprecedented accuracy and sensitivity with simplified data analysis that eliminates the need for bioinformatics. TempO-Seq assays deliver an easy to use solution for customers doing expression profiling for any species.
Booth: A55
UK-based Cambridge Environmental Assessments (CEA) provides specialist regulatory support and consultancy services relating to human health and environmental chemical risk assessment. Our current global client base spans a diverse range of sectors that includes agrochemicals, biocides, consumer products, chemicals in food (including enzymes), and industrial chemicals. Our teams comprise of specialists in environmental fate and behaviour; field-fate studies and stewardship; exposure and spatial modelling; aquatic ecotoxicity testing (laboratory and mesocosm studies); ecotoxicology and risk assessment; toxicology and human health risk assessment; and regulatory affairs.
Booth: A42
For over 70 years, Charles River has served the world’s industries by
• supporting 86% of novel FDA approved drugs in 2021
• helping 1000+ industrial chemicals reach the market
• assisting in the approval of 34+ agrochemical actives.
Our scientific experts leverage an expansive safety assessment portfolio, a range of laboratory support services, and global state-of-the-art facilities to produce the quality data you need to optimize your product development program – every step of the way.
Toxicology expertise includes general toxicology, immunotoxicology, genetic, ocular, neuro, developmental and reproductive toxicology (DART), and more.
Booth: B06
The Chinese Society of Toxicology (CST) is a non-profit national academic organization composed of the experts and professionals in the field of toxicological science and technology in China. CST was founded in November 10, 1993, is one of the national organizations affiliated to the China Association for Science and Technology (CAST) and registered at the Ministry of Civil Affairs of the People’s Republic of China. CST is an active member of the International Union of Toxicology (IUTOX) and a founding member of the Asian Society of Toxicology (ASIATOX).
Booth: B04
Concept Life Sciences is a UK-based research organisation (CRO/CDMO) offering world-class toxicology and chemistry services to support clients through discovery and development. With over 25 years of experience, we provide high-quality scientific solutions, ensuring regulatory compliance and accelerating success.
Our toxicology services cover in vitro, screening, investigative, and regulatory studies, supporting pharmaceuticals, biotechnology, agrochemicals, and chemical industries. We offer tailored, GLP-compliant studies, generating reliable safety data for informed decision-making.
CLS’s chemistry support takes clients from discovery to KG scale production, supporting and accelerating timelines along chemical development pathways. We have great expertise in applying AI to early discovery and in careful management of process development to deliver safe efficient synthetic routes.
Our success is built on communication, problem prevention and excellence of delivery.
Booth: A22
Cyprotex, an Evotec company, specializes in predictive toxicology and ADME-PK, offering high-quality in vitro assays and predictive in silico models. With state-of-the-art labs in Framingham, MA, and Alderley Park, UK, Cyprotex enhances human exposure prediction and clinical outcomes, supporting the de-risking of drug development.
Learn more at www.evotec.com and www.cyprotex.com
Booth: A49
DNTOX offers animal experiment-free toxicological testing services with a focus on developmental and adult neurotoxicity. By combining human cell-based 2D/3D test systems with state-of-the-art machine learning technology, DNTOX provides a faster, more cost-effective and more human-relevant alternative to traditionally used rodent studies. Next to regulatory purposes, these cost- and time-effective tests can be implemented as routine screening during the development of new chemicals and pharmaceuticals. Our innovative services facilitate the development of chemicals that are safe and sustainable by design and thereby contribute to the protection of customer health and the EU Chemicals Strategy for Sustainability Towards a Toxic-Free Environment.
Booth: A47
Dynamic42 GmbH provides immunocompetent, physiological organ-on-chip models combining ISO-certified, medical-grade standards with ease of use for scientists. As a spin-off from the University Hospital Jena in Germany, the company has developed a strong background in disease and infection modeling. Dynamic42 offers contract research for preclinical drug evaluation in human models of the vasculature, liver, intestine, and lung as well as customized model development. The company further is producer of the DynamicOrgan System the open organ-on-chip platform, provides a variety of medical-grade, low drug adsorption biochips and hands-on as well as online training courses within their Dynamic42 Academy.
Booth: A58
ECETOC is a non-profitassociation that brings together experts from academia, industry, and regulators to advance chemical safety science. We develop frameworks, tools, and recommendations that support evidence-based decision-making in Europe, promoting environmental and human health protection.
Booth: A07
Ellegaard Göttingen Minipigs A/S was founded to supply scientists in biomedical research with a better non-rodent animal model with many similarities to humans, a high-quality health standard, but also small and easy to handle. Today, Göttingen Minipigs are fully recognized as an established animal model by all regulatory authorities worldwide. From our AAALAC-accredited facility in Denmark, we breed Göttingen Minipigs, IgG Humanized Göttingen Minipigs, and provide scientific research services to enable the development of safer and more effective medicines, all based on our core values: Animal welfare, Quality, Respect, and Collaboration.
Booth: A51
emka TECHNOLOGIES provides innovative tools to streamline the acquisition, analysis, and reporting of physiological data for non-clinical toxicology studies.
Our offerings feature mobile acquisition stations, paperless recordings, automated batch analysis, GLP-compliant and SEND-validated reporting for both snapshot and long-term studies.
Using the telemetry technology, we provide implantable and non-invasive options (easyTEL+, emkaPACK), delivering high-quality signals and coverage to meet diverse experimental needs in rodent and large animal research.
Our studyDESIGNER software manages data workflows, from acquisition to analysis, simplifying GLP and non-GLP studies with modular, fully integrated tools to enhance efficiency and reproducibility.
Booth: A50
Epithelix is a leader for in vitro assessment of drug efficacy and toxicity of inhaled chemicals or mixtures on human respiratory tract. Epithelix has developed unique 3D in vitro human airway tissues (MucilAir™, SmallAir™ and AlveolAir™) and testing services for studying airway pathologies like Asthma, Cystic Fibrosis, Pulmonary Fibrosis, Chronic Obstructive Pulmonary Diseases, Bacterial and Viral infections.
Booth: A32
ERBC Group is a 50 years’ leading CRO committed to bridge the gap between preclinical and clinical research by better predicting the efficacy and safety of new compounds offering innovative in vitro and in vivo translational models and services.
Offering a comprehensive range of experimental capabilities, preclinical models, and consultancy services, ERBC allows biopharmaceutical and chemical industry professionals to de-risk innovation and enhance R&D productivity.
With highly qualified teams in France and Italy, ERBC is offering a customer-centric approach while committed in improving all aspects of study design and conduct applying alternatives to animal testing as a priority.
Booth: A45
At ESQlabs we specialize in developing advanced simulation models for the pharmaceutical, chemical, crop and healthcare industries. Our PBK and multi-scale organism-level QSP models are designed to predict the effects of chemicals and biologics on different populations and species, supporting research and development by assessing pharmacokinetics, efficacy, and safety. We pride ourselves on our commitment to integrity and excellence in everything we do.
Booth: A52
We assist companies with the development and life cycle management of their medical devices, through our global network of 80+ regulatory experts, 20+ laboratories, and 2 sterile packaging sites in Europe, North America, & Asia Pacific. Companies of all sizes benefit from our 40+ years of expertise and capabilities to ready their products for market launch and post-marketing activities through three independent services: consulting, testing, and sterile packaging.
Our extensive experience in commercialisation processes, regulatory requirements, and industry trends ensures rapid turnaround of your project with the highest level of service and most advanced technologies.
Our Services: consulting – testing – sterile packaging
Booth: B01
The European Chemicals Agency (ECHA) works for the safe use of chemicals. ECHA is the driving force among regulatory authorities in implementing the EU’s ground breaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness. We – help companies to comply with the legislation, – advance the safe use of chemicals, – provide information on chemicals and – address chemicals of concern. We are a modern, science-driven organisation with ca. 600 staff members. ECHA was set up in 2007 and is located in Helsinki, Finland.
Booth: B10
Booth: A39
ICCR-Roßdorf and Kaly-Cell in the GBA Group are leading contract research organization with more than 30 years of toxicological experience. We offer our customers excellent analytical services in pharmaceuticals, chemicals, agrochemicals, cosmetics and medical devices.
Regulatory testing for mutagenicity, genotoxicity and cytotoxicity is the focus of our activities. We are equally specialized in in-vitro ADME-Toxicology with hepatocytes and/or liver subcellular fractions to evaluate inter-species differences and inter-individual variability in safety and drug efficacy to explain adverse reactions. In-vitro methods in the field of sensitisation as well as irritation and corrosion on skin and eye models complete the analytical portfolio. For testing the biocompatibility of medical devices, we have many years of experience in the testing of extracts in accordance with ISO 10993-1. In addition, batch release tests of pharmaceuticals under the GMP quality standard is available.
Booth: B02
The General Chemical State Laboratory (G.C.S.L.) is a service within the Independent Authority of Public Revenue (IAPR) which operates at General Directorate level. The mission of the General Chemical State Laboratory (G.C.S.L.) is to provide public authorities and citizens with high quality technical services, with the ultimate purpose of:
• Safeguarding public revenue, through the scientific assistance and technical support of the IAPR authorities and the Ministry of Finance or on its own
• Protecting public health, the environment and consumer interests
• Providing scientific support to judicial, police as well as other state authorities and Services
• Supporting the proper function of the market and strengthening competitiveness and innovation of the chemical industry in collaboration with other competent authorities.
• Development and worldwide promoting of national products for the benefit of the national economy.
• Providing the national infrastructure for chemical metro
Booth: A29
GenoSafe is an analytical CRO providing testing services for the evaluation of quality, safety and efficacy of Gene and Cell therapies. GenoSafe brings its 20-year experience in the development, qualification and validation of analytical methods to perform preclinical biodistribution, shedding and immunogenicity studies according to Good Laboratory Practices – GLP.
GenoSafe will also provide its continuous support for clinical bioanalysis of patient samples (i.e immunogenicity, biodissemination and gene expression studies) as well as QC testing of your drug candidates.
Booth: B17
At helloR&D, we are revolutionizing liver toxicity prediction for novel drugs, compounds, and chemicals. Leveraging our proprietary HeLLOs – advanced hepatocyte organoids – we offer a cutting-edge liver toxicity testing service that delivers mechanistic insights with unprecedented accuracy and relevance.
Our platform goes beyond basic screening. We empower drug developers with data-driven guidance that supports informed decision-making, accelerates R&D, and reduces the risk of late-stage failures.
Let’s work together to reduce liver toxicity and create safer chemicals, faster.
Booth: A23
ImmuONE is a biotechnology CRO company dedicated to advancing human-relevant, non-animal inhalation safety and efficacy testing. Specialising in innovative cell-based models, we develop cutting-edge solutions to assess the safety of airborne substances, helping industries such as pharmaceuticals, chemicals, and consumer goods move away from outdated animal testing methods. Our validated and standardised lung and immune models provide highly predictive and ethical alternatives for evaluating respiratory toxicity. With a strong focus on research, regulatory engagement, and industry collaboration, ImmuONE is revolutionising inhalation toxicology, ensuring safer products reach the market. Our mission is clear to ‘make every breath safe’ through scientific innovation and human-relevant testing.
Booth: A38
Inotiv provides deep expertise and scientific capabilities across the discovery and continuum. We support our clients from the beginning of discovery, through investigational new drug (IND) and beyond, all with the aim of delivering a superlative experience.
Combined with our long history and deep experience with supply of critical research models, including rodents, rabbits, and nonhuman primates, Inotiv is the right-sized CRO for your next project.
With our dedication to attentive, decisive service, you can trust that every program is a priority. Benefit from our long and impeccable regulatory history, world-class team of scientists, and on-time quality data delivery.
Booth: A48
InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology. Through partnerships, InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding the human physiology in vitro. Its robust and precisely engineered suite of 3D InSight™ human tissue platforms are used by major pharmaceutical companies worldwide to increase efficiency in drug discovery and safety testing. The scalable Akura™ technology underlying the company’s 3D InSight™ Discovery and Safety Platforms includes 96 and 384-well plate formats and the Akura™ Flow organ-on-a-chip system to drive efficient innovation throughout all phases of drug development.
Booth: A28
Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products
Booth: A67
IIVS is a GLP-compliant Contract Research Organization focused on non-animal alternatives to toxicology and product safety testing. We work with industry (including chemical, pharmaceutical, cosmetic and personal care companies) as well as academic and government organizations, performing testing services in non-animal models. In addition, IIVS assists in the validation of New Approach Methodologies (NAMs) to traditional assays. As a non-profit entity, our laboratory activities and contributions fund our Education and Outreach programs, providing extensive training and active involvement in the advocacy and promotion of non-animal methods worldwide. For more information, visit www.iivs.org.
Booth: A06
INVITROLIZE commercializes ALIsens, an in vitro model able to identify and differentiate respiratory sensitizers from irritants or “innocent” chemicals.
Booth: B09
J-TEC offers LabCyte, reconstructed human tissue models as alternatives to animal testing, leveraging its advanced cell culture technology based on the expertise of providing high quality regenerative medical products.
– LabCyte EPI-MODEL：Reconstructed human epidermis, listed in OECD TG439 skin irritation test, TG431 skin corrosion test, and TG442D skin sensitization test (EpiSensA).
– LabCyte CORNEA-MODEL: Reconstructed human corneal epithelium, listed in OECD TG492 eye irritation test.
LabCyte has a structure and morphology that parallels those of human tissues, supporting experiments in highly physiological conditions.
J-TEC has commercialized 5 regenerative medical products in Japan (autologous cultured epidermis, cartilage, etc.). Utilizing the cell culture technology developed by the late Prof. Howard Green of Harvard Medical School, we have built an advanced manufacturing and quality control system, stably supplying regenerative medical products for years.
Booth: A68
Jimbio Technology focuses on related applications in the life
sciences and aims at the ELED (every lab every day) market in
biological basic applications, and develops detection and related
application platform products based on microfluidic chip technology.
Booth: A21
JOINN Laboratories (China) Co., Ltd. (Stock Code: 603127.SSE/6127.HK) is dedicated to providing drug R&D CRO outsourcing services with over 2000 professionals. JOINN has built a thorough quality management system complied with international standards: CNAS/ILAC-MRA certification, NMPA, US FDA, OECD, Japan PMDA and Korean MFDS GLP certification and international AAALAC accreditation. JOINN can provide customized services tailored to the client’s specific needs for non-clinical safety assessments, clinical trials, registrations, and pharmacovigilance which cover the entire spectrum from development to final drug registration. JOINN also provides services in animal feed and veterinary medicine evaluation, pesticide evaluation, medical device evaluations, and more.
Booth: A35
JRF Global is a pre-clinical Contract Research Organization with a presence in 9 countries across the globe, with over 47 years of specialized experience under OECD GLP. Our extensive facility spans more than 500,000 sq. ft. and features dedicated laboratories for Discovery, Custom synthesis, Toxicology, Product Chemistry, Analytical Chemistry, Ecotoxicology, and Environmental Fate and Metabolism studies.
JRF has over 60 designated rooms for various animal species, fully compliant with AAALAC standards. JRF has state-of-the-art Analytical and Bioanalytical laboratories run by over 100+ chemists with diverse experience analyzing chemicals, pharmaceuticals, UVCBs and Biologicals. JRF houses several cell culture rooms for in vitro research. JRF’s Toxicology team of over 150+ scientists possess extensive experience in comprehensive range of toxicology studies that adhere to rigorous regulatory submissions to Global regulators.
Booth: A26
KREATiS is a unique, private Research & Development company specialising in predictions for Human health and environment, replacing or re-thinking experimentation with confidence. Combining the available quality experimental data with sophisticated modelling algorithms, we develop iSafeRat® High Accuracy QSARs (HA-QSARs) and use also the best third-party software for in silico consulting; our goal is to provide the most accurate study predictions for physicochemical and (eco)toxicological study for organic molecules. State-of-the-science approaches are implemented to address a well-defined Applicability Domain as well as to demonstrate the robustness and predictive ability of our models following the QSAR assessment framework for regulatory submissions.
Booth: A12
Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Learn more about us at www.labcorp.com.
Booth: A61
At Lhasa, we are driven by our purpose; To enable informed decision making on chemical safety. In line with this purpose, we create forward-thinking software solutions, which solve real-world chemical safety assessment problems. Our technology is designed by scientists, for scientists, in collaboration with industry stakeholders and regulators.
Our exhibitor hosted sessions discuss using weight of evidence to improve carcinogenicity, DART, and skin sensitisation safety assessments, using in silico tools to meet the latest nitrosamine regulatory updates and using read-across to support nitrosamine risk assessment.
Booth: A10
LifeNet Health LifeSciences gives healing every advantage by providing research solutions that empower groundbreaking discoveries around the world. Our goal is to improve health and safety for humankind by providing all-human cells, in vitro physiological systems, biospecimens for research, and cytotoxicity services. We support scientists in the pharmaceutical, biotech, agriscience, food safety, and cosmetic industries.
Booth: A08
Lonza Bioscience Solutions provides life science researchers in academic and government institutions as well as major biotech and pharmaceutical organizations worldwide with the tools they need to develop and test critical disease-treating drugs and therapies, from basic research to final product release, including cell culture and discovery technologies, quality control tests and software for biomanufacturing.
Booth: A11
Łukasiewicz – IPO Branch in Pszczyna conducts scientific research, development, and implementation works in the areas of toxicology, ecotoxicology, fate and behaviour in the environment, and physical-chemical properties in determining the degree of hazard coming from chemical substances, their mixtures, and biological substances to the warm-blooded organisms and the environment.
The studies are conducted within the framework of national and European projects, and joint research projects implemented in cooperation with scientific institutions and industrial companies.
Booth: A63
MatTek Life Sciences is a leader in tissue engineering technology, providing lab-grown human tissues from the skin, eye, respiratory system, and digestive systems. These tissues are used globally as ethical and human-relevant alternatives to animal testing. MatTek’s tissues are known for their unmatched reproducibility with multiple regulatory approvals and validations from organizations such as the OECD, ISO, and the US EPA. They effectively predict the irritation, corrosion, and photosensitivity potential of chemicals, pharmaceuticals, cosmetics, and other skincare products. Product formulation scientists in the cosmetic, personal care, chemical, and pharmaceutical industries prefer MatTek tissues for their distinctive ability to provide human-relevant responses that are often more predictive of clinical outcomes.
Booth: A59
As a leading Contract Research Organization (CRO), Medicilon has been at the forefront of pharmaceutical R&D for over 20 years. We have assisted more than 2,000 global clients and contributing to the IND approval of over 490 drugs.
Booth: A41
The Metafer Platform Software for automated microscopy supports genetic toxicology laboratories globally by automating various microscope-based workflows. This enables laboratories to not only save time during evaluations but also achieve a high level of standardization in their processes. Such standardization enhances result reproducibility and streamlines testing procedures, ensuring adherence to GLP (Good Laboratory Practice) standards and compliance with relevant OECD guidelines.
Booth: A53
We develop microfluidic prototypes as part of EU consortia to solve researchers’ problems. At the same time, we test the market interest in these prototypes and transform them into products. Once the business model has been established and the financing plan validated, we license the tech or create a new deeptech spinoff.
Booth: A13
MileCell provides products & CRO services to pharmaceutical companies and research laboratories , support preclinical research, clinical studies from Phase I to Phase III, and commercialization.
Booth: A64
Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, transforming scientific discoveries into practical treatments for personalized medicine. With over 35 years of expertise, it supports biomedical discoveries and translates them into clinical applications, enhancing patient access to new therapies. Miltenyi Biotec focuses on offering integrated solutions for complex challenges in treating cancers, autoimmune diseases, and inherited disorders. Its Miltenyi Bioindustry division provides expert guidance to therapy developers efficiently from process development to commercialization. Headquartered in Bergisch Gladbach, it employs 4,900 people across 24 countries.
Booth: A60
Molecular Networks Altamira (MN-AM) offers innovative solutions in computational toxicology empowering new approach methodologies (NAMs) for next generation risk assessment (NGRA) of chemicals for human-health relevant endpoints of regulatory importance. MN-AM’s ChemTunes·ToxGPS® chemoinformatics platform including the Express system provides a unique combination of in vivo, in vitro, and eco-toxicity databases, bioavailability data, and a knowledgebase of WOE-based, reliability-driven ML- and AI-based tools and workflows for in silico predictions, TTC analysis, assessment of structural, biological, and physicochemical similarity of compounds, metabolite identification, POD bounds calculations, and consistent, reproducible, and transparent end-point specific read-across for making better chemical safety decisions.
Booth: B11
MP Biomedicals offers a wide range of diagnostic solutions, including rapid tests for infectious diseases, quantitative rapid tests, confirmatory assays, and drug of abuse (DoA) tests. Our CE-marked products are manufactured under strict international regulatory standards, ensuring accuracy and reliability for healthcare providers, researchers, employers, and health organizations.
We provide 16 saliva and 39 urine drug detection parameters in various formats (strip, card, dip card, cup), with customizable combinations. To complement this range, our portable drug test reader enables scanning, digitalization, and printing of results, optimizing workflow efficiency.
With MP Biomedicals, you gain access to trusted, high-quality diagnostics designed for precision, speed, and ease of use—helping you make better healthcare decisions.
Booth: A31
MultiCASE creates advanced software and QSAR models to evaluate new chemicals’ pharmacological activity, toxicity, and metabolic pathways. Many of these innovations stem from a long-standing research partnership with the US FDA.
Booth: A54
Nagi Bioscience is a Swiss-based high-tech company developing cutting-edge biological testing solutions that help scientists generate the insights they need to drive life-changing discoveries in a faster, more efficient, and ethical way. Our technologies integrate seamlessly into existing lab environments, enhancing efficiency, accuracy, and reproducibility. By combining innovative solutions with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance their research.
Booth: B03
The Nikon BioImaging Lab offers contract research services for microscopy-based imaging and analysis tailored to biotech, pharma, and research communities. We excel in four key areas:
Speed – Advanced imaging hardware and expertise enable rapid setup, while in-house cell culture capabilities streamline assay development.
Quality – Backed by over 100 years of Nikon’s leadership in optical and digital imaging, we deliver versatile, high-performance solutions.
Reproducibility – Precision hardware and custom software ensure low variability and exceptional accuracy.
Flexibility – Custom configurations meet diverse imaging needs.
Our expert team provides cell culture, sample preparation, data acquisition, and analysis, supporting your research goals.
Booth: B07
The NUVISAN group is a full-service contract research and development and manufacturing organization (CRO/CDMO) with state-of-the-art laboratories in Germany and France.
Our pharmaceutical, biotechnology, venture capital and non-profit clients partner with us because our high-quality end-to-end solutions and scientific expertise enable us to streamline and accelerate drug discovery and development – from ensuring target understanding to helping bring therapeutics to life.
Booth: A43
OmicScouts empowers drug discovery and biotech innovation at the forefront of (chemical) proteomics. We specialize in tailored mechanism-of-action studies, target deconvolution and selectivity profiling, as well as protein turnover analysis. Our diverse assay portfolio integrates advanced bioinformatics and cell culture expertise to deliver comprehensive and scalable solutions from study design to data interpretation.
Booth: A17
PhoenixBio is a global leader in the development and distribution of high-quality human liver models. Our PXB-mouse is a humanized liver animal model and has a liver repopulated with up to 98% human hepatocytes. PXB-cells are human hepatocytes freshly isolated from the PXB-mouse and are frequently applied for in vitro research.
PhoenixBio models accelerate pharmaceutical and chemical compound development due to their unique ability to deliver preclinical insights that are more predictive of human outcomes. Our models are applied in several research areas, including viral hepatitis (HCV, HBV, HBV/HDV), MASH/MAFLD, Gene Therapy & Editing, DMPK/Toxicology, and more!
Booth: A09
pixlbio: iPSC-Powered Phenomics
pixlbio is the result of a strategic merger between DefiniGEN Limited (UK) and Phenaros Pharmaceuticals (Sweden), bringing together iPSC expertise and AI-driven phenomics to support pre-clinical drug development. We provide drug screening including MoA studies and toxicity testing, as well as disease modeling using iPSCs enhanced by phenomics technology. Our automated pipeline captures over 1.4M images and profiles 300M+ cells, mapping 3.6 billion morphological features to biological insights with precision and scale – in a week.
Core Offerings:
- iPSC-Derived Models: High-purity hepatocytes, stellates and intestinal organoids, and validated disease models for MASH/MASLD, A1ATD, and Wilson’s disease
- Phenomics Platform: AI-powered analysis revealing disease mechanisms, drug responses, and cellular states
- Custom Automation: Proprietary robotics and microscopy systems delivering scalable, high-fidelity results
- SaaS Solutions: Direct access to predictive models and phenomics data
Booth: B13
PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development.
Whatever the therapeutic areas, you need to base your clinical development on robust and valuable cardiovascular data.
To secure first-in-human development and offer new safe therapies to patients, PhysioStim provides first-in-class know-how with unique and predictive models to define the POC of drug discovery with gold-standard and customized models, to investigate secondary pharmacology with on and off-target liabilities, to address the safety purpose and support your IND applications (with mandatory and complementary assays).
Booth: A16
Platelet Services is a contract research organisation providing full-range, independent pre-clinical services in platelet testing. We offer an array of standard and customised platelet testing assays to determine the effect of compounds on platelet function. With clients that include both small drug discovery companies and large pharmaceutical corporations, we are uniquely placed to offer comprehensive support in drug discovery and development where platelet testing is required.
Booth: B12
PLUSBIO is a company specializing in primate-related business. We offer health management solutions designed for all primate species, available for purchase globally. We aim for our solution to play a significant role in addressing the health management challenges faced by many research institutes and production facilities.
Booth: A56
With our Scientist-to-Scientist approach we support you at every step of the preclinical development, providing the best scientific advice and offering tailored solutions for small Molecules, biologics, gene and cells therapies.
We have a recognized international reputation for in vitro, ex vivo, and in vivo expertise in physiopathological models, customized procedures, histology, biomarkers, and solutions for discovering treatments in over 10 different therapeutic areas (CNS, Cardiovascular, GI).
Booth: A27
PRIMACYT offers one of the world’s most comprehensive portfolios of liver related products obtained from human and animal species like birds, fresh and seawater fish, rodents, and farm animals. We offer primary human and animal cells, liver subcellular fractions, ex vivo full thickness and/or dermatomed human skin explants, blood derived cells, and consumables for applications in preclinical testing and product development in human and animal health and environmental safety evaluations. Products are manufactured in accordance with OECD test guidelines.
We are GLP certified, offer medical device testing services and act as a reference laboratory for the European Union.
Booth: A69
ProtoQSAR is a Spanish SME specialized in computational (in silico) toxicology and the safe, sustainable, and efficient design and development of chemicals. We are experts in the latest AI-powered chemoinformatics and molecular modelling tools, including QSAR models, molecular docking, virtual screening, etc.. We work in toxicology, chemistry, biotech, pharma, veterinary, cosmetics, nutraceuticals, materials, and agrifood sectors. We have experience in 10+ HORIZON research projects in toxicology and related fields. Our QSAR models allow for the prediction and assessment of physicochemical, biological, therapeutical, pharmacological (e.g. ADME), and/or (eco)toxicological properties of substances with an array of advantages: speed, low cost, regulatory validity, no animal testing (3Rs). Many of them, including the largest available QSAR platform for REACH, can be directly accessed (including a free trial) at www.protoqsar.com
Booth: A20
QACS Labs provide Quality Control Laboratory Testing services to the Cosmetic, Pharmaceutical, Biocides and Food industries since 2002.
With an ISO 17025 accredited, ISO 9001 certified, FDA registered and GMP & GLP certified quality management system, QACS Labs provide Microbiological – Chemical – Molecular Testing & Regulatory solutions worldwide.
Booth: A36
Regulatory Science Associates (RSA) is a consultancy made up of toxicology consultants, other technical experts and regulatory affairs specialists who bring decades of combined experience from the agrochemical, pharmaceutical, biocide and general chemical industries that we use to support our clients. We are an enthusiastic and dedicated team with strengths in toxicology consulting, human health exposure and risk assessment, as well as ecotoxicology and environmental risk assessment services. RSA’s aim is to provide technically robust scientific solutions, supporting our clients in achieving and maintaining regulatory compliance for their products.
Booth: B15
SafeBridge is the premier resource for high-level safety and health consulting to the pharmaceutical and biotechnology industry. Founded in 1997, the team includes more than 50 professionals who provide the Potent Compound Safety Triangle® of services, namely, toxicology, industrial hygiene, and industrial hygiene analytical chemistry. Our specific expertise is in the recognition, evaluation, and control of potential worker exposure and product safety issues associated with the handling of potent and highly potent drug substances and drug products. In addition to the work we have traditionally performed for the pharmaceutical industry, we also provide services related to the registration and approval of food and beverage ingredients and biocides, general industry industrial hygiene services, and quality assurance of non-clinical toxicology studies.
Booth: A04
Scantox is a preclinical GLP-accredited CRO, specialized in providing services within the drug development process Discovery, Genetic Toxicology, Regulatory Toxicology and Pharmaceutical Development & Analytical. Based on decades of experience, we are a trusted partner for CRO services for the pharmaceutical and medical devices industries. The Scantox Group is headquartered in Ejby, Denmark, with subsidiaries in UK, Austria, Denmark and Sweden (Lund and Gothenburg).
Scantox services enable clients to progress their drug or device development based on solid data to the highest technical and scientific standards. The Scantox team is passionate about the common vision to improve the health of people, and all processes are rooted in dedication and guided by a strong sense of purpose.
Booth: A24
SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. SenzaGen’s GARDskin assay was adopted by OECD as part of Test Guideline 442E for in vitro skin sensitization, with confirmed performance and demonstrated applicability for “difficult-to-test” chemicals such as complex mixtures, indirectly acting haptens, lipophilic compounds and metals.
Booth: A25
Sequani is a UK based Preclinical Contract Research Organisation specialising in preclinical toxicology studies.
Sequani’s services include:
+ GLP and OECD Study designs
+ General toxicology in rodents, rabbit, dog and minipig models
+ Reproductive & Juvenile toxicity
+ Genetic toxicology
+ Biomarkers
+ Analytical chemistry for formulation analysis
+ Bioanalysis
+ Pharmacokinetics and toxicokinetic reporting
+ Clinical pathology
+ Pathology
+ Histotechnology
+ Contract histology and pathology
+ Foetal pathology
+ Programme management
We work across
o drug development
o crop protection
o chemical
o food safety
Contact: business.development@sequani.com
Booth: A34
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries.
StageBio represents the combined capabilities of the most well-respected sources of high-quality histology and histopathology services in the preclinical and clinical research and development market.
The company operates 4 state of the art facilities, 3 in the US and 1 facility in Europe, serving customers across the Americas, Europe, Australia, and Asia. We continue to make substantial investments in our facility and technology infrastructure to meet the growing demand for high-quality histopathology services.
At StageBio we have a team of 25+ board-certified veterinary pathologists and more than 100 laboratory staff supporting our unified commitment to quality, scientific integrity and client satisfaction.
Booth: A05
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene’s more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and world-class manufacturing at speed to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2.2 Mn sq. ft of specialist facilities, Syngene works with biotech companies pursuing leading-edge science, such as GSK, Zoetis, and Merck KGaA.
Booth: A57
TEAM Mastery specializes in Chemical Regulatory Affairs, offering a broad range of services backed by expertise in chemistry, biology, toxicology, pharmacology, human health, and environmental risk assessment. Our skilled team delivers innovative, scientifically rigorous solutions across the supply chain, ensuring timely and reliable support. Committed to respecting human health and the environment, we employ advanced in vitro and in silico methods for precise, regulation-compliant risk assessments. Guided by excellence and responsibility, we aim to shape a safer, more sustainable future through cutting-edge strategies and unwavering dedication to quality.
Booth: A02
TissUse is the pioneering force in the field of multi-organ-chip technology, driving innovation since 2010. Our commercially available HUMIMIC Multi-Organ-Chips offer a unique opportunity to model the complexities of human organs and their interactions. By leveraging our cutting-edge technology, you can make informed decisions during the drug development process. Predict toxicity and efficacy, and evaluate ADME profiles in vitro, all while reducing the dependence on animal testing and streamlining clinical trials. Trusted by academic and industry leaders, TissUse empowers you to obtain comprehensive safety and efficacy data, revolutionizing the future of research.
Booth: A65
ToxMinds BVBA is a product safety and regulatory compliance consultancy headquartered in Brussels and a subsidiary office in Bangalore. Its team of consultants serve clients from the cosmetics, chemical, and pharmaceutical industries. Passionate about toxicology and leveraging emerging new approach methodologies, the team supports customers in bringing safe, regulatory-compliant, and sustainable products to market. The ToxMinds team is specialised in identifying assessment and testing strategies to fill safety information gaps without any further animal testing. ToxMinds has a proven track record for successful submissions of risk assessments under existing cosmetics, chemicals, biocides, and medicinal product regulatory frameworks.
Booth: A33
Toxys is a Dutch biotech company with a subsidiary in the USA that develops NAMs and offers a broad spectrum of innovative in vitro toxicology solutions for the safety assessment of novel pharmaceuticals, chemicals, cosmetics, medical devices, and food. With our unique assays that provide insights into the mode of action, including ToxTracker, ReproTracker, and ToxProfiler, we are known as experts in the fields of genotoxicity, developmental toxicology and mechanistic toxicity testing. Toxys is currently working with most of the top 10 global pharma companies and major chemical, cosmetics, and food multinationals.
Booth: B14
Union Biometrica COPAS FP™, BioSorter® and COPAS Infinity™ Large Particle Flow Cytometers automate analysis and sorting of objects too big/fragile for traditional cytometers, e.g., large cells/clusters, cells in/on beads and small model organisms (2-1500 micron diameter). The COPAS Vision™ cytometer adds brightfield image capture on the fly for convenient identification of objects. The VAST BioImager™ and VAST FluoroImager™ platforms automatically load and rotationally orient 2-7 dpf zebrafish larvae for organ-level imaging in brightfield and fluorescence respectively.
Booth: A40
VIMTA is a leading Contract Research and Testing Organization which was established in 1984 and it is driven by its vision and enduring strength. VIMTA’s business landscape includes analytical, clinical, preclinical services to life sciences industries; quality and safety testing for food and beverage industries; Testing and Certification in Electrical & Electronics industries; and environment services to a wide spectrum of industries.
Booth: A15
VITROCELL® is specialised in the development of advanced in vitro exposure systems. VITROCELL® realizes turnkey installations for in vitro inhalation toxicology where gases, environmental atmospheres, nanoparticles and complex mixtures are analyzed on lung cells at the air/liquid interface.
The company offers relevant exposure technologies for continuous flow exposure, liquid aerosols using Cloud single droplet sedimentation as well as for small quantities of dry powders.
VITROCELL® in vitro Exposure Stations are designed for fully automated exposure of environmental pollutants to cells of the respiratory tract.
VITROCELL® Skin modules are specially designed for the exposure of tissue.
A complete set of dosimetry tools is an essential part of the product program.
The customers of VITROCELL Systems GmbH are leading research institutes, contract research organisations, regulatory authorities as well as the pharmaceutical and other industries throughout the world.
Booth: A19
We are passionately committed to our role in enhancing the quality of human lives. We are a unique, world-class, globally integrated testing platform supporting the entire continuum of the drug development journey. From discovery through preclinical to clinical and beyond, we enable scientists to transform their ideas into healthcare products that ultimately improve life.
We are dedicated to providing you and your program with the highest level of attention. Our subject matter experts (SMEs) are there with you every step of the way, to collaborate and work through the unique challenges of drug discovery and development.
As your partner, you have access to a team that operates with full transparency and industry leading turnaround times. We provide the insights and high-quality data you need to advance your project to the next milestone while meeting international standards for regulatory compliance.
In case of any questions, please do not hesitate to contact us:
EUROTOX 2025 Sponsorship & Exhibition
